{
  "folder": "IC-332",
  "content": "{{knowledge objective\n|Identifiant=OIC-332-13-A\n|Item_parent=Shock. Main aetiologies: hypovolaemic, septic (see item 158), cardiogenic, anaphylactic.\n|Item_parent_short=Shock. Main aetiologies: hypovolaemic, septic (see item 158), cardiogenic, anaphylactic.\n|Rank=A\n|Title=Know the principles of management of anaphylactic shock\n|Description=see item 332\n|Heading=Management\n|Contributors=Julien Poissy\n|Order=13}}\n\nAnaphylactic shock requires first-line injection of IM adrenaline!\n\nStep 1: Condition monitoring and venous lines (see elements for immediate management of a state of shock)\n\nStage 2: management of shock\n\n- Avoidance of the allergen\n\n- Injection of adrenaline IM ++.\n\n- Auto-injector pen if available\n\n- Adrenaline ampoule 1mg diluted in 10 mL. Injection 0.01 mg/kg (0.5 mg per 50 kg)\n\n- Location: lateral surface of the middle 1/3 thigh, in the vastus lateralis\n\n- The IV route is possible but should be reserved for trained teams: titration +++ 0.001 mg/kg (10 times less than IM!)\n\n- Repeat every 5 minutes\n\n- Crystalloid volume expansion\n\nStage 3: Investigation and management of associated respiratory failure\n\n- If respiratory distress: patient in sitting position\n\n- Lower airway obstruction: aerosols of \u03b22-mimetics (salbutamol)\n\n- Upper airway obstruction: aerosols of adrenaline (5 mg nebulised)\n\n\nNB: IV corticosteroid therapy with 1 mg/kg methylprednisolone is not an emergency and is used to prevent relapse. Antihistamines are only effective on mucocutaneous signs.",
  "question": {
    "question": "What is the recommended first-line treatment for anaphylactic shock?",
    "option_a": "Avoidance of the allergen",
    "option_b": "Use of adrenaline IM ++",
    "option_c": "Use of adrenaline ampoule 1mg diluted in 10 mL. Injection 0.01 mg/kg (0.5 mg per 50 kg)",
    "option_d": "Use of adrenaline ampoule 1mg diluted in 10 mL. Injection 0.001 mg/kg (10 times less than IM!)",
    "correct_option": "option_b"
  }
}